Current role
Sven Guenther
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Zevra Therapeutics, Inc. (ZVRA)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Zevra Therapeutics, Inc. (ZVRA) | Executive vice president, research and development | $398,982 | $1,082,153 |
| 2020 | Zevra Therapeutics, Inc. (ZVRA) | Executive vice president, research and development | $374,792 | $563,331 |
| 2019 | Zevra Therapeutics, Inc. (ZVRA) | Executive vice president, research and development | $363,875 | $687,731 |
| 2018 | Zevra Therapeutics, Inc. (ZVRA) | Executive vice president, research and development | $353,333 | $693,606 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.